Androgenic Alopecia

Dermatology
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Plus Therapeutics
1 program
400mg /day during 6 monthsN/A1 trial
Active Trials
NCT01852487CompletedEst. Dec 2012
Pierre Fabre
Pierre FabreFrance - Aignan
1 program
RV4986A lotionN/A1 trial
Active Trials
NCT06576492Completed30Est. Jun 2023
MEDIPOST
MEDIPOSTKorea - Gyeonggi
1 program
conditioned media of umbilical cord blood-derived stem cellsN/A1 trial
Active Trials
NCT03676400CompletedEst. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pierre FabreRV4986A lotion
MEDIPOSTconditioned media of umbilical cord blood-derived stem cells
Plus Therapeutics400mg /day during 6 months

Clinical Trials (3)

Total enrollment: 30 patients across 3 trials

Assessment of the Effects and Tolerance of the RV4986A Lotion in Men With AGA After Hair Transplant

Start: Jul 2021Est. completion: Jun 202330 patients
N/ACompleted
NCT03676400MEDIPOSTconditioned media of umbilical cord blood-derived stem cells

Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia

Start: Oct 2018Est. completion: Jul 2019
N/ACompleted
NCT01852487Plus Therapeutics400mg /day during 6 months

Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia

Start: Feb 2012Est. completion: Dec 2012
N/ACompleted

Related Jobs in Dermatology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space